Morepen Enters U.S. Prescription Generics Market with the Launch of its Desloratadine Tablets, Complementing Broader API, R&D and CDMO Growth Strategy
Nov 09, 2026
New Delhi [India], November 9: Morepen Laboratories Limited announced the launch of its first prescription (Rx) generic product, Desloratadine Tablets USP, 5 mg, in...